Heterogeneity of intratumoral 111In-ibritumomab tiuxetan and 18F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin’s lymphoma
Crossref DOI link: https://doi.org/10.1186/s13550-015-0093-3
Published Online: 2015-03-14
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hanaoka, Kohei
Hosono, Makoto
Tatsumi, Yoichi
Ishii, Kazunari
Im, Sung-Woon
Tsuchiya, Norio
Sakaguchi, Kenta
Matsumura, Itaru
License valid from 2015-03-14
Article History
Received: 23 January 2015
Accepted: 25 February 2015
First Online: 14 March 2015